These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 8292848)

  • 41. [Synthesis and biological activity of analogs of a nonapeptide inhibitor of peptidyldipeptidase].
    Filatova MP; Krit NA; Beschastnaia NV; Blokhina AV; Kozlova NI
    Bioorg Khim; 1985 Jan; 11(1):21-30. PubMed ID: 2985089
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structural relationships of angiotensin converting-enzyme inhibitors to pharmacologic activity.
    Ondetti MA
    Circulation; 1988 Jun; 77(6 Pt 2):I74-8. PubMed ID: 2836111
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Synthesis and analysis of conformationally restricted analogs of peptide inhibitors of the angiotensin-converting enzyme].
    Filatova MP; Krit NA; Komarova OM; Orekhovich VN; Reissmann S
    Bioorg Khim; 1986 Jan; 12(1):59-70. PubMed ID: 3004512
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Silanediol inhibitors of angiotensin-converting enzyme. Synthesis and evaluation of four diastereomers of Phe[Si]Ala dipeptide analogues.
    Kim J; Hewitt G; Carroll P; Sieburth SM
    J Org Chem; 2005 Jul; 70(15):5781-9. PubMed ID: 16018669
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential effects of angiotensin converting enzyme inhibitors on the vasodepressor and prostacyclin responses to bradykinin.
    Brown NJ; Ryder D; Gainer JV; Morrow JD; Nadeau J
    J Pharmacol Exp Ther; 1996 Nov; 279(2):703-12. PubMed ID: 8930174
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of angiotensin converting enzyme by L-alanyl-4 or 5-substituted-L-prolines and their N alpha-phosphoryl-derivatives.
    Alexandrou EN; Liakopoulou-Kyriakides M
    Biochem Int; 1990; 21(2):271-8. PubMed ID: 2403366
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of angiotensin-converting enzyme by dipeptide analogs.
    Schwab A; Macerata R; Rogers W; Barton J; Skiles J; Khandwala A
    Res Commun Chem Pathol Pharmacol; 1984 Sep; 45(3):339-45. PubMed ID: 6095384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Solid phase synthesis of retro-inverso peptide analogues. Synthesis and biological activity of the partially modified retro-inverso analogue of the bradykinin potentiating peptide BPP9a [gLys6, (RS)-mPhe7, Ala8] BPP9a.
    Bonelli F; Pessi A; Verdini AS
    Int J Pept Protein Res; 1984 Dec; 24(6):553-6. PubMed ID: 6099336
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structure-activity relationships for kininase II inhibition by lower homologs of the bradykinin potentiating peptide BPP9a.
    Fisher GH; Ryan JW; Martin LC; Pena GA
    Adv Exp Med Biol; 1979; 120B():651-63. PubMed ID: 229714
    [No Abstract]   [Full Text] [Related]  

  • 50. Structure and activity of angiotensin I converting enzyme inhibitory peptides derived from Alaskan pollack skin.
    Byun HG; Kim SK
    J Biochem Mol Biol; 2002 Mar; 35(2):239-43. PubMed ID: 12297036
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthetic peptides corresponding to alpha-lactalbumin and beta-lactoglobulin sequences with angiotensin-I-converting enzyme inhibitory activity.
    Mullally MM; Meisel H; FitzGerald RJ
    Biol Chem Hoppe Seyler; 1996 Apr; 377(4):259-60. PubMed ID: 8737991
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isolation and characterization of a new bradykinin potentiating octapeptide from gamma-casein.
    Lebrun I; Lebrun FL; Henriques OB; Carmona AK; Juliano L; Camargo AC
    Can J Physiol Pharmacol; 1995 Jan; 73(1):85-91. PubMed ID: 7600458
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systematic screening for bioactive peptides.
    Maeji NJ; Bray AM; Valerio RM; Seldon MA; Wang JX; Geysen HM
    Pept Res; 1991; 4(3):142-6. PubMed ID: 1726649
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk.
    Nakamura Y; Yamamoto N; Sakai K; Okubo A; Yamazaki S; Takano T
    J Dairy Sci; 1995 Apr; 78(4):777-83. PubMed ID: 7790570
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Molecular descriptors of amino acids for the evaluation of the physicochemical parameters and biological activity of peptides].
    Tiunina EIu; Badelin VG
    Bioorg Khim; 2009; 35(4):501-9. PubMed ID: 19928052
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New proline-rich oligopeptides from the venom of African adders: Insights into the hypotensive effect of the venoms.
    Kodama RT; Cajado-Carvalho D; Kuniyoshi AK; Kitano ES; Tashima AK; Barna BF; Takakura AC; Serrano SM; Dias-Da-Silva W; Tambourgi DV; Portaro FV
    Biochim Biophys Acta; 2015 Jun; 1850(6):1180-7. PubMed ID: 25688758
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.
    Sagardia I; Roa-Ureta RH; Bald C
    Food Chem; 2013 Feb; 136(3-4):1370-6. PubMed ID: 23194537
    [TBL] [Abstract][Full Text] [Related]  

  • 58. QIGLF, a novel angiotensin I-converting enzyme-inhibitory peptide from egg white protein.
    Yu Z; Zhao W; Liu J; Lu J; Chen F
    J Sci Food Agric; 2011 Mar; 91(5):921-6. PubMed ID: 21384361
    [TBL] [Abstract][Full Text] [Related]  

  • 59. N-protected tripeptide inhibitors of angiotensin converting enzyme.
    Kayahara H; Ohashi A; Tadasa K; Kato S
    Agric Biol Chem; 1990 May; 54(5):1325-6. PubMed ID: 1368622
    [No Abstract]   [Full Text] [Related]  

  • 60. An angiotensin converting enzyme inhibitor is a tight-binding slow substrate of carboxypeptidase A.
    Martin MT; Holmquist B; Riordan JF
    J Inorg Biochem; 1989 May; 36(1):39-50. PubMed ID: 2746220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.